Target intelligence / Profile preview

Unconventional myosin-Va (MYO5A) (MYO5A)

Target
MYO5A
Molecular classification
Enzyme, Molecular motor, ATPase, Cytoskeletal protein, Actin-binding protein
01

Overview

Unconventional myosin-V is a class of actin-based motor proteins that play a vital role in the intracellular transport of organelles and vesicles. In humans, the family comprises three isoforms (Va, Vb, and Vc), with Myosin Va being the most extensively studied for its role in transporting melanosomes in skin cells and synaptic vesicles in the brain (1). Mutations in the MYO5A gene are the primary cause of Griscelli syndrome type 1, a rare autosomal recessive disorder characterized by pigmentary dilution and severe neurological impairment (2). Myosin Vb is critical for membrane recycling in epithelial cells, and its dysfunction leads to microvillus inclusion disease, a life-threatening diarrheal condition (3). From a therapeutic perspective, Myosin V is an emerging target in oncology, as it facilitates the transport of vesicles containing pro-migratory factors that drive cancer cell invasion and metastasis (4). While small molecule inhibitors like pentachloropseudilin are used in research to probe its ATPase cycle, there are currently no FDA-approved drugs specifically targeting Myosin V, though it remains a significant focus for treating pigmentary and neurodegenerative conditions (5). Citations: (1) UniProt Consortium. "Unconventional myosin-Va (P42108)." UniProtKB. (2) Pastural, E., et al. (1997). "Griscelli disease maps to chromosome 15q21 and is associated with mutations in the myosin-Va gene." Nature Genetics. (3) Müller, T., et al. (2008). "MYO5B mutations cause microvillus inclusion disease and disrupt epithelial cell polarity." Nature Genetics. (4) Fedoryshchak, R. O., et al. (2020). "Small molecule inhibitors of unconventional myosins." ACS Chemical Biology. (5) Hammer, J. A., & Sellers, J. R. (2012). "Walking to work: roles for class V myosins as cargo transporters." Nature Reviews Molecular Cell Biology.

Other names
Myosin-VaMyosin VDilute myosin heavy chain non-muscleMyosin heavy chain 12MYH12MYO5Unconventional myosin-VMyosin VbMyosin Vc
02

Mechanism of action

Small molecule inhibitors typically target the ATPase activity of the motor domain or interfere with the actin-binding cycle, thereby preventing the translocation of cargo along actin filaments.

03

Biological functions

Intracellular transportVesicle traffickingMelanosome transportSynaptic plasticityOrganelle positioningCell polarityActin-based motility
04

Disease associations

Griscelli syndrome type 1Microvillus inclusion diseaseElejalde syndromeCancer metastasisNeurodevelopmental disordersPigmentation disorders
05

Safety considerations

Off-target effects on other myosin classesNeurotoxicity due to impaired synaptic vesicle transportGastrointestinal distress from Myo5b inhibitionImpaired immune cell trafficking
06

Interacting drugs

Pentachloropseudilin

3 more in the full profile.

07

Biomarkers

MYO5A gene mutationsMelanosome distribution in melanocytesRab27a/Myo5a/Melanophilin complex levelsMicrovillus atrophy in intestinal biopsies

Beyond the preview

Go deeper on Unconventional myosin-Va (MYO5A) (MYO5A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Unconventional myosin-Va (MYO5A) (MYO5A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call